NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1750479952 MD
Verify on CMS → Motaz Agabani, MD
Endocrinology, Diabetes & Metabolism Physician in Sarasota, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
5K
Medicare Part D claims · 686 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
42%
generic claims · 53% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · Above neutral
Industry payments
$738.88
36 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Motaz Agabani, MD reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 4,698 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 5K
- Part D claims, 2023
- 42%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Motaz Agabani, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Motaz Agabani, MD sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,521 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Motaz Agabani, MD writes more Part D claims than 77% of them and scores higher on MIPS quality than 15% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Motaz Agabani, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Motaz Agabani, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Motaz Agabani, MD?
Below national averagePrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
4,698 78% vs specialty avg
MIPS final score
75/100 8.1 pts vs avg
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Motaz Agabani, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 75/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Motaz Agabani, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 2650 BAHIA VISTA, Sarasota, FL, 34239, with a listed phone of (941) 330-8355. NPI 1750479952 was issued on 10/11/2006.
Medicare Part D records for calendar year 2023 show 4,698 prescription claims written by this provider, covering 686 Medicare beneficiaries and totaling roughly $2.1 million in drug spend, split 53% brand-name and 42% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1750479952 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/11/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
Avg: 83.1
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Motaz Agabani, MD. Source: openpaymentsdata.cms.gov.
Total received
$739
Largest payer
Dexcom, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Motaz Agabani, MD. To verify Motaz Agabani, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Motaz Agabani, MD - brand share 53.0%
Endocrinology, Diabetes & Metabolism Physician average
53% brand-name claims vs 42% generic, on 4,698 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,698
Total Claims
$2.1M
Total Drug Cost
686
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 12,787
- Total Day Supply
- 381,776
- Brand vs Generic
- 53% brand / 42% generic
- Brand Drug Cost
- $2.0M
- Generic Drug Cost
- $50K
Patient Demographics
- Average Patient Age
- 74.8 years
- Avg HCC Risk Score
- 1.47
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 37, 65-74: 307, 75-84: 260, 85+: 82
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Motaz Agabani, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
1,099 claims
- Glimepiride
Glimepiride
464 claims
- Metformin Hcl 315
Metformin Hcl
315 claims
- Synthroid 273
Synthroid
273 claims
- Jardiance 108
Jardiance
108 claims
- Trulicity 108
Trulicity
108 claims
- Tresiba Flextouch … 103
Tresiba Flextouch U-200
103 claims
- Pioglitazone Hcl 85
Pioglitazone Hcl
85 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 1,099 |
| Glimepiride | 464 |
| Metformin Hcl | 315 |
| Synthroid Levothyroxine Sodium | 273 |
| Jardiance Empagliflozin | 108 |
| Trulicity Dulaglutide | 108 |
| Tresiba Flextouch U-200 Insulin Degludec | 103 |
| Pioglitazone Hcl | 85 |
| Ozempic Semaglutide | 83 |
| Novolog Flexpen Insulin Aspart | 80 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in FL →
All providers in Florida →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Motaz Agabani, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Motaz Agabani, MD's 4,698 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Agabani.
Dr. Ejigayehu Abate
MD
Jacksonville, FL
Dr. Susan Abend
M.D.
Sarasota, FL
Dr. Daisy Acevedo Morales
MD
South Miami, FL
Dr. Brenda Acosta Ashby
MD
Doral, FL
Dr. Adriane Adami
APRN
Panama City, FL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Florida medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Florida
Frequently Asked Questions
What is Motaz Agabani, MD's specialty? ▼
Motaz Agabani, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Sarasota, Florida. Credentials: MD.
How much does Motaz Agabani, MD prescribe under Medicare Part D? ▼
In 2023, Motaz Agabani, MD wrote 4,698 Medicare Part D claims totaling $2.1M in drug costs for 686 beneficiaries.
What is Motaz Agabani, MD's Medicare quality score? ▼
Motaz Agabani, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Motaz Agabani, MD located? ▼
Motaz Agabani, MD is located at 2650 BAHIA VISTA, Sarasota, FL, 34239. Phone: (941) 330-8355.
What is Motaz Agabani, MD's NPI number? ▼
Motaz Agabani, MD's National Provider Identifier (NPI) is 1750479952, issued on 10/11/2006.
Does Motaz Agabani, MD prescribe more brand-name or generic drugs? ▼
Motaz Agabani, MD's prescribing is 53% brand-name and 42% generic drugs by claim count, with $2.0M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Motaz Agabani, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Motaz Agabani, MD's most frequently prescribed drugs include Levothyroxine Sodium, Glimepiride, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Motaz Agabani, MD accept Medicare? ▼
Motaz Agabani, MD appears in CMS Medicare data with 4,698 Part D claims and 686 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Motaz Agabani, MD's credentials? ▼
Motaz Agabani, MD's NPI is 1750479952 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.